Factors of Importance for Prediction of Survival in Patients with Metastatic Renal Cell Carcinoma, Treated with or without Nephrectomy
Author:
Affiliation:
1. Department of Surgical and Perioperative Surgery, Urology and Andrology, Umeå University, S-901 85 Umeå, Sweden
Publisher
Informa UK Limited
Subject
Urology,Nephrology
Link
https://www.tandfonline.com/doi/pdf/10.1080/003655900750041979
Reference20 articles.
1. Natural history and therapy of metastatic renal cell carcinoma
2. Sobin LH, Wittekind Ch, editors. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997: 180–2.
3. Heterogeneity in renal cell carcinoma and its impact on prognosis - a flow cytometric study
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden;PLOS ONE;2021-06-22
2. Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting;Scandinavian Journal of Urology;2020-09-08
3. Epidemiology, Risk Assessment, and Biomarkers for Patients with Advanced Renal Cell Carcinoma;Urologic Clinics of North America;2020-08
4. Testicular metastasis from renal cell carcinoma after nephrectomy and on tyrosine kinase inhibitors therapy: Case report and review;Urologia Journal;2019-02-01
5. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma;The Bone & Joint Journal;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3